Latest News about VRTX
Recent news which mentions VRTX
Earnings Scheduled For May 1, 2023
May 01, 2023
From Benzinga
The Best Stocks to Invest $5,000 in Right Now
May 01, 2023
From Motley Fool
From Motley Fool
3 Unstoppable Stocks to Buy Right Now
April 29, 2023
From Motley Fool
ImmunoGen Boosts Annual Guidance On Upbeat Uptake Of Newly Approved Ovarian Cancer Drug
April 28, 2023
From Benzinga
2 Growth Stocks That Could Double in 5 Years
April 27, 2023
From Motley Fool
3 Cash-Rich Biotech Stocks to Bet on for the Long Haul
April 25, 2023
From InvestorPlace
From Motley Fool
3 Healthcare Stocks That Could Help Make You a Fortune
April 24, 2023
From Motley Fool
With FDA Submission For Sickle Cell Gene Therapy, Bluebird Bio Can Potentially Have 3 Approved Products By 2023
April 24, 2023
From Benzinga
The Best Stocks to Invest $20,000 in Right Now
April 23, 2023
From Motley Fool
Berkshire Hathaway, Gilead Sciences, Vertex Pharmaceuticals And A Break-Out Casino Stock Feature On CNBC's 'Final Trades'
April 21, 2023
From Benzinga
Better Big Biotech Buy: Biogen vs. Vertex
April 20, 2023
From Motley Fool
Have $1,000? 2 Explosive Growth Stocks to Buy and Hold No Matter What the Market Does Next
April 20, 2023
From Motley Fool
Got $5,000? Buy and Hold These Fast-Growing Stocks for Years
April 18, 2023
From Motley Fool
3 High-Growth Biotech Stocks Poised for Success in 2023
April 18, 2023
From InvestorPlace
From Motley Fool
The Top Healthcare Stocks to Buy With $100
April 18, 2023
From Motley Fool
Why CRISPR Therapeutics Stock Is Marching Higher Today
April 17, 2023
From Motley Fool
Why Shares of Editas Medicine Rose Monday
April 17, 2023
From Motley Fool
Which Stocks Pass Warren Buffett's $10,000 Test?
April 17, 2023
From Motley Fool
From Motley Fool
Is CRISPR Therapeutics Stock a Buy Now?
April 14, 2023
From Motley Fool
Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?
April 13, 2023
From InvestorPlace
$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis
April 13, 2023
From Benzinga
2 Nasdaq Growth Stocks That Are Screaming Buys in April
April 13, 2023
From Motley Fool
From Benzinga
Could This Move Make Vertex's Next Blockbuster Even Bigger?
April 12, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.